Varenicline administration for smoking cessation may reduce apnea hypnea index in sleep apnea patients
A. Pataka (Thessaloniki, Greece), C. Frantzidis (Thessaloniki, Greece), P. Gkivogkli (Thessaloniki, Greece), C. Nday (Thessaloniki, Greece), P. Chriskos (Thessaloniki, Greece), M. Karagianni (Thessaloniki, Greece), H. Styliadis (Thessaloniki, Greece), E. Paraskevopoulos (Nicosia, Cyprus), C. Kourtidou-Papadeli (Thessaloniki, Greece), P. Bamidis (Thessaloniki, Greece)
Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Pataka (Thessaloniki, Greece), C. Frantzidis (Thessaloniki, Greece), P. Gkivogkli (Thessaloniki, Greece), C. Nday (Thessaloniki, Greece), P. Chriskos (Thessaloniki, Greece), M. Karagianni (Thessaloniki, Greece), H. Styliadis (Thessaloniki, Greece), E. Paraskevopoulos (Nicosia, Cyprus), C. Kourtidou-Papadeli (Thessaloniki, Greece), P. Bamidis (Thessaloniki, Greece). Varenicline administration for smoking cessation may reduce apnea hypnea index in sleep apnea patients. 751
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: